NCT05016310 2025-07-23
A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation
Wake Forest University Health Sciences
Phase NA Completed
Clinical Trials
15 trialsNCT03629717 2024-10-16
RANKL Inhibition and Breast Tissue Biomarkers
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT01224678 2024-10-08
Vitamin D and Breast Cancer Biomarkers in Female Patients
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT02186015 2021-05-14
SAFE-D
Loyola University
Phase 2 Completed
NCT04166253 2021-02-03
VDDOXO
Damanhour University
Phase 2 Completed
NCT04091178 2019-09-16
OPTIVIT
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Completed
NCT00656019 2017-12-02
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Stanford University
Phase 2 Completed
NCT01425476 2017-08-09
Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors
Hartford Hospital
Phase 1/2 Completed
NCT01965522 2017-06-16
MELO-D
Juravinski Cancer Center
Phase 2 Completed
NCT00022087 2016-07-19
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00054418 2016-07-13
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00073073 2016-05-17
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
Georgetown University
Phase 2 Completed
NCT01948128 2016-02-03
OTT 12-06
Ottawa Hospital Research Institute
Phase 2 Completed
NCT00263185 2014-09-22
High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT01240213 2013-08-07
ViDA
Fred Hutchinson Cancer Center
Phase NA Completed